Year: 2026

Tempest Reports Year End 2025 Financial Results and Provides Business Update

Written by Customer Service on March 30, 2026. Posted in Earnings Releases And Operating Results.

Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the ongoing REDEEM-1 Phase 1/2a trial of TPST-2003 in patients with relapsed/refractory multiple myeloma (rrMM) BRISBANE, Calif., March 30, 2026 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today reported financial results for the year ended December 31, 2025, and provided a corporate update. “2025 was a transformative year for Tempest as we strengthened our pipeline with the strategic acquisition of a portfolio of next-generation CAR-T assets,” said Matt Angel, Ph.D., President and Chief...

XBP Global Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Written by Customer Service on March 30, 2026. Posted in Earnings Releases And Operating Results.

IRVING, Texas, March 30, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a multinational technology and services company orchestrating mission-critical systems that enable hyper-automation and digital transformation, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. Following the transformative acquisition of Exela Technologies BPA, LLC (“BPA”) in July 2025, the Company is reporting results that reflect a significant transition period. To provide a clearer view of the combined business’ performance, the Company has included pro forma metrics alongside reported GAAP results, with reconciliations to the most comparable GAAP metrics in this release, where applicable. Reported results exclude the results of our European operations (“XBP...

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Written by Customer Service on March 30, 2026. Posted in Public Companies.

Tel Aviv, Israel, March 30, 2026 (GLOBE NEWSWIRE) — Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that Nuclear Quantum, a portfolio company of its wholly-owned subsidiary, Quantum X Labs Ltd. (“Quantum X Labs”), has achieved a strategic milestone. Nuclear Quantum has advanced in its roadmap, focused on bringing its proprietary quantum-based simulation algorithms to leading nuclear and engineering simulation companies worldwide. This milestone marks the Nuclear Quantum’s strategy progress from core technology algorithm development to potential targeted industry engagement, addressing a critical and growing need: the modernization of legacy simulation methodologies through quantum computation. As part of this milestone, Nuclear Quantum is initiating a focused strategy to...

Jeffs’ Brands Announces Corporate Name Change to Nexera Technologies and New Nasdaq Ticker Symbol “NEXR”

Written by Customer Service on March 30, 2026. Posted in Public Companies.

Tel Aviv, Israel, March 30, 2026 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW) today announced that effective as of March 26, 2026, it has officially changed its corporate name to Nexera Technologies Ltd. (“Nexera”), reflecting the Company’s strategic shift toward advanced technologies and homeland security solutions. It is expected that effective March 31, 2026, the Company’s ordinary shares will begin trading on the Nasdaq Capital Market under the new ticker symbol “NEXR”, replacing the previous ticker “JFBR.” The Company’s warrants are expected to trade under the symbol “NEXRW,” replacing the previous ticker “JFBRW.” The corporate name change follows the Company’s previously announced rebranding initiative and strategic repositioning to focus on homeland security technologies,...

Baiya International Group Inc. Sets Sail, the Market Takes the Helm: The “Cryptocurrency Ark Plan” Begins with a Global Vote to Determine Its First Allocation Direction

Written by Customer Service on March 30, 2026. Posted in Public Companies.

Shenzhen, China, March 30, 2026 (GLOBE NEWSWIRE) — Baiya International Group Inc. (“BIYA” or the “Company”) (Nasdaq: BIYA), a human resource (“HR”) technology company utilizing its cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions, today announced the official launch of its Cryptocurrency Ark Plan (the “Plan”), alongside the introduction of a global voting mechanism to determine the direction of its next phase of digital asset allocation. This initiative marks an evolution in the Company’s asset allocation strategy, establishing a more structured framework under the Plan that integrates market-driven decision-making with a disciplined allocation approach. Global Vote Begins: Letting the Market Decide the Ark’s First Destination The Company plans to launch a one-week global...

Clean Energy Technologies Advances First Waste-to-Energy Deployment in Alberta Under LOI with Hoppy Power, Targeting Scalable Rollout

Written by Customer Service on March 30, 2026. Posted in Public Companies.

IRVINE, CA, March 30, 2026 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (“CETY” or the “Company”), a clean energy technology and solutions provider focused on converting waste and heat into power and fuels, today announced the execution of a non-binding Letter of Intent (“LOI”) with Hoppy Power Ltd. (“Hoppy Power”) to evaluate and advance the deployment of CETY’s proprietary High Temperature Ablative Pyrolysis (HTAP™) technology for waste-to-energy applications. This initiative represents a meaningful step toward near-term deployment and initial commercialization, with defined milestones in 2026 expected to include engineering validation, permitting progression, and advancement toward definitive agreements. The Company anticipates providing further updates as these milestones are achieved, supporting...

KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

Written by Customer Service on March 30, 2026. Posted in Public Companies.

Next-Generation Agentic AI Platform Achieves Live Enterprise Deployment, Delivering Secure, Scalable, Autonomous Research Solutions to Global Biotechnology and Pharmaceutical Organizations ARLINGTON, Mass., March 30, 2026 (GLOBE NEWSWIRE) — KALA BIO, Inc. (NASDAQ: KALA) (“Kala” or the “Company”) today announced the initial commercial deployment of the Bionic Intelligence Research Agent (BIRA), the Company’s first purpose-built agentic AI solution delivered through its Researgency.ai platform (under exclusive worldwide license with Younet). This milestone marks Kala’s transformation into an operational AI infrastructure partner for the global biotechnology industry. The launch follows the Company’s March 11 announcement that its first AI agent would ship within 14 days, a commitment Kala has met on schedule, demonstrating...

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones

Written by Customer Service on March 30, 2026. Posted in Public Companies.

– Full enrollment of BLA-enabling trial complete, per prior guidance –– Topline NEXICART-2 Results Expected Q3 2026, followed by BLA submission and planned commercial launch – – Onboarded Chief Medical Officer, formerly of Merck and Johnson & Johnson for BLA submission – LOS ANGELES, CA, March 30, 2026 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that NEXICART-2 enrollment is complete, meeting Company guidance, with topline results expected in Q3 2026, followed by BLA submission and planned commercial launch. “In AL Amyloidosis, the immune system produces toxic light chains that clog up the heart, kidney and liver, causing organ failure and death. In our trials, we have seen that one-and-done NXC-201 eliminates...

Schouw & Co. share buy-back programme, week 13 2026

Written by Customer Service on March 30, 2026. Posted in Mergers And Acquisitions.

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK Accumulated until 20 March 2026 96,283 670.79 64,585,477 Monday, 23 March 2026 1,000 593.00 593,000 Tuesday, 24 March 2026 1,000 622.00 622,000 Wednesday, 25 March 2026 1,000 642.00 642,000 Thursday, 26 March 2026 1,000 638.80 638,804 Friday,...

Willis Lease Finance Corporation Amends Revolving Credit Facility

Written by Customer Service on March 30, 2026. Posted in Public Companies.

COCONUT CREEK, Fla., March 30, 2026 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced that it has amended and extended its existing revolving credit facility, increasing total commitments from $1.0 billion to $1.75 billion and extending the maturity to April of 2031. The amended facility was oversubscribed, with approximately $1.0 billion in excess lender commitments, reflecting strong support from the Company’s lenders/partners. “We are very pleased to complete the expansion and extension of our revolving credit facility, reflecting the strength and confidence the markets have in our platform,” said Scott B. Flaherty, EVP & Chief Financial Officer of Willis Lease Finance...

Year: 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals